| 6.32 0.87 (15.96%) | 02-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 7.38 |
1-year : | 8.62 |
| Resists | First : | 6.32 |
Second : | 7.38 |
| Pivot price | 5.3 |
|||
| Supports | First : | 4.82 |
Second : | 3.9 |
| MAs | MA(5) : | 5.49 |
MA(20) : | 5.07 |
| MA(100) : | 4.25 |
MA(250) : | 2.54 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 87.2 |
D(3) : | 81.4 |
| RSI | RSI(14): 75.3 |
|||
| 52-week | High : | 6.32 | Low : | 0.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ IMRA ] has closed Bollinger Bands are 9.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.32 - 6.34 | 6.34 - 6.36 |
| Low: | 5.13 - 5.15 | 5.15 - 5.17 |
| Close: | 6.27 - 6.31 | 6.31 - 6.35 |
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Sun, 09 Jun 2024
Imran Khan on co-parenting daughter Imara post divorce with Avantika Malik: 'We remind her these are grow - TOI Etimes
Thu, 23 May 2024
Imran Khan Reveals How He Manages To Co-Parent His Daughter, Imara: 'From Thursday To Sunday...' - BollywoodShaadis.com
Thu, 23 May 2024
Imran Khan says his daughter Imara lives with him from Thursday to Sunday, wonders what’ll happen when he restarts working - The Indian Express
Tue, 06 Feb 2024
Imran Khan moved out of bungalow, sold Ferrari and left films to fix himself - Hindustan Times
Tue, 09 Jan 2024
Imran Khan Poses With Daughter Imara, Mom Nuzhat, Lekha Washington At Ira Khan’s Mehendi - Outlook India
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 26 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 16.6 (%) |
| Held by Institutions | 71.3 (%) |
| Shares Short | 341 (K) |
| Shares Short P.Month | 1,370 (K) |
| EPS | -2.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.77 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -34.2 % |
| Return on Equity (ttm) | -57.5 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.71 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -46 (M) |
| Levered Free Cash Flow | -30 (M) |
| PE Ratio | -2.54 |
| PEG Ratio | 0 |
| Price to Book value | 1.67 |
| Price to Sales | 0 |
| Price to Cash Flow | -3.6 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|